Sexual Dysfunction in Unmedicated Patients with Schizophrenia and in Healthy Controls

Abstract

Introduction Sexual dysfunction figures prominently in patients with schizophrenia; however, medication effects may play a role. The objective of this case control study was to assess differences in the presence of sexual dysfunction in unmedicated patients with schizophrenia versus healthy controls.

Methods Sexual dysfunction was assessed using the Derogatis Inventory for Sexual Function self-rating in a cross-sectional design controlling for age and gender effects. A brief sexual anamnesis was applied to describe the psychosocial background of the mostly male sample further.

Results Results show a significant difference with patients reporting more problems in most domains and with a significant correlation between severity of psychosis (Positive and Negative Syndrome Scale total scores) and the impairment of orgasm experience. The study revealed reduced sexual activities and less pleasure during sexual activities of patients.

Discussion This study implies that schizophrenia has an impact on the presence of sexual dysfunction and that sexual dysfunction is partly independent of antipsychotic treatment. Since the sample consisted mostly of first-episode males, conclusions might only be valid for this subgroup.

Key words

libido - sexual dysfunction - schizophrenia - unmedicated - DISF-SR

• References

• 1 Marneros A, Andreasen NC, Tsuang MT. Negative and Positive Schizophrenia. Berlin: Springer; 1991
• 2 Andreasen NC, Flaum M, Swayze II VW. et al. Positive and negative symptoms in schizophrenia a critical reappraisal. Arch Gen Psychiatry. 1990; 47: 615-621
• 3 Andreasen NC, Arndt S, Alliger R. et al. Symptoms of schizophrenia methods, meanings, and mechanisms. Arch Gen Psychiatry. 1995; 52: 341-351
• 4 Aizenberg D, Zemishlany Z, Dorfman-Etrog P. et al. Sexual dysfunction in male schizophrenic patients. J Clin Psychiatry. 1995; 56: 137-141
• 5 Cutler AJ. Sexual dysfunction and antipsychotic treatment. Psychoneuroendocrinology 2003; 28 (Suppl. 01) 69-82
• 6 de Boer M, Castelein S, Wiersma D. et al. The facts about sexual (dys)function in schizophrenia: an overview of clinically relevant findings. Schizophr Bull. 2015; 41: 674-686
• 7 Marques TR, Smith S, Bonaccorso S. et al. Sexual dysfunction in people with prodromal or first-episode psychosis. Br J Psychiatry. 2012; 201: 131-136
• 8 Basson R. Human sex-response cycles. J Sex & Marital Ther 2001; 27: 33-43
• 9 Kaplan HS. Hypoactive sexual desire. J Sex & Marital Ther 1979; 3: 3-9
• 10 Masters WH, Johnson VE. Human Sexual Response. Toronto, New York: Bantam Books; 1966
• 11 Crow TJ. Molecular pathology of schizophrenia: more than one disease process?. BMJ 1980; 280: 1-9
• 12 Pogue-Geile MF. Harrow M. Negative symptoms in schizophrenia: their longitudinal course and prognostic importance. Schizophr Bull. 1985; 11: 427-439
• 13 Strauss JS, Carpenter WT. The prediction of outcome in schizophrenia II: relationship between predictors and outcome variables. Arch Gen Psychiatry. 1974; 31: 37-42
• 14 Malik P, Kemmler G, Hummer M. et al. Sexual dysfunction in first-episode schizophrenia patients: results from European First Episode Schizophrenia Trial. J Clin Psychopharmacol. 2011; 31: 274-280
• 15 González-Blanco L, Greenhalgh AM, Garcia-Rizo C. et al. Prolactin concentrations in antipsychotic-naïve patients with schizophrenia and related disorders: A meta-analysis. Schizophr Res. 2016; 174: 156-160
• 16 Rajkumar RP. Prolactin and psychopathology in schizophrenia: A literature review and reappraisal. Schizophr Res Treatment 2014; 2014: 175360
• 17 Heinz A. Dopaminergic dysfunction in alcoholism and schizophrenia – psychopathological and behavioral correlates. Eur Psychiatry. 2002; 17: 9-16
• 18 Baggaley M. Sexual dysfunction in schizophrenia: Focus on recent evidence. Hum Psychopharmacol 2008; 23: 201-209
• 19 Knegtering H, van der Moolen AE, Castelein S. et al. What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning?. Psychoneuroendocrinology 2003; 28 (Suppl. 02) 109-123
• 20 Montejo AL, Montejo L, Navarro-Cremades F. Sexual side-effects of antidepressant and antipsychotic drugs. Curr Opin Psychiatry. 2015; 28: 418-423
• 21 Dossenbach M, Arango-Dávila C, Silva Ibarra H. et al. Response and relapse in patients with schizophrenia treated with olanzapine, risperidone, quetiapine, or haloperidol: 12-month follow-up of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study. J Clin Psychiatry. 2005; 66: 1021-1030
• 22 Raja M, Azzoni A. Sexual behavior and sexual problems among patients with severe chronic psychoses. Eur Psychiatry. 2003; 18: 70-76
• 23 Macdonald S, Halliday J, MacEwan T. et al. Nithsdale Schizophrenia Surveys 24: sexual dysfunction. Case-control study. Br J Psychiatry. 2003; 182: 50-56
• 24 Sheehan DV, Lecrubier Y, Sheehan KH. et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59 (Suppl. 20) 22-33
• 25 First MB, Spitzer RL, Gibbon M. et al User’s Guide for the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID I). Washington DC: American Psychiatric Press, Inc; 1996
• 26 Derogatis LR. The Derogatis Interview for Sexual Functioning (DISF/DISF-SR): an introductory report. J Sex Marital Ther. 1997; 23: 291-304
• 27 Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987; 13: 261-276
• 28 Olfson M, Uttaro T, Carson WH. et al. Male sexual dysfunction and quality of life in schizophrenia. J Clin Psychiatry. 2005; 66: 331-338
• 29 Kelly DL, Conley RR. Sexuality and schizophrenia: A review. Schizophr Bull. 2004; 30: 767-779
• 30 Krüger TH, Haake P, Haverkamp J. et al. Effects of acute prolactin manipulation on sexual drive and function in males. J Endocrinol. 2003; 179: 357-365
• 31 Kumsar NA, Kumsar Ş, Dilbaz N. Sexual dysfunction in men diagnosed as substance use disorder. Andrologia 2016; 48: 1229-1235
• 32 Peugh J, Belenko S. Alcohol, drugs and sexual function: a review. J Psychoactive Drugs. 2001; 33: 223-232
• 33 Preskorn SH. Clinically important differences in the pharmacokinetics of the ten newer “atypical” antipsychotics. (part 1): J Psychiatr Pract. 2012; 18: 199-204